The medication works by reducing appetite and increasing satiety, which leads to a lower calorie intake and an initial rapid weight loss
Harnessing glucagon-like peptide-1 receptor agonists for the pharmacological treatment of overweight and obesity
Review of clinical trial data on Ozempic and hair loss Clinical data shows that about 0.80% of patients reported telogen effluvium or non-scarring hair loss within six months after starting Semaglutide at 0.25-2mg weekly doses [7]
They may also contact their insurance company directly to ascertain coverage and benefits, Ali said.
A notable research effort, known as the STEP (Semaglutide GLP-1 Treatment Effect in People with Obesity) trial, revealed that participants taking Semaglutide GLP-1 achieved an average weight reduction of around 15% of their starting body weight within 68 weeks, unlike those taking a placebo
Retinoid products reduce discoloration and promote skin cell turnover [20]